This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tarkowski, E. Articles by Tarkowski, A. Search for Related Content PubMed PubMed Citation Articles by Tarkowski, E. Articles by Tarkowski, A. Pubmed/NCBI databases Substance via MeSH Related Collections Apoptosis Cell signalling/signal transduction Growth factors/cytokines Acute Cerebral Infarction

(Stroke. 1999;30:321-327.)
© 1999 American Heart Association, Inc.

Original Contributions

Intrathecal Expression of Proteins Regulating Apoptosis in Acute Stroke

E. Tarkowski, MD, PhD; L. Rosengren, MD, PhD; C. Blomstrand, MD, PhD; C. Jensen, MD; S. Ekholm, MD, PhD A. Tarkowski, MD, PhD

From the Departments of Rheumatology and Clinical Immunology (E.T., A.T.), Clinical Neurosciences (Section of Neurology) (E.T., L.R., C.B.), and Radiology (C.J., S.E.), University of Göteborg, Göteborg, Sweden.

Correspondence to Dr Elisabeth Tarkowski, Departments of Rheumatology and Clinical Immunology, Guldhedsgatan 10, S-413 46 Göteborg, Sweden. E-mail andrej.tarkowski{at}microbio.gu.se

Background and Purpose—The neuronal death that accompanies an ischemic stroke has previously been attributed to a necrotic process. However, numerous studies in experimental models of ischemia have recently indicated that programmed cell death, also called apoptosis, may contribute to neuronal death. The aim of the present study was to investigate the intrathecal levels of proteins regulating apoptosis in acute stroke and to relate these levels to brain damage and to production of proinflammatory and anti-inflammatory cytokines.

Methods—Thirty stroke patients were studied prospectively on days 0 to 4, 7 to 9, 21 to 26, and after day 90 with clinical evaluation, radiological assessment, and analysis of cerebrospinal fluid (CSF) levels of soluble (s) Fas/APO-1 and sbcl-2, 2 proteins that regulate apoptosis. In addition, analysis of the intrathecal levels of cytokines interleukin (IL)-1ß, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor- was performed. Nineteen CSF samples from healthy subjects were used for control purposes. The patients were examined with MRI 1 to 3 months after stroke onset for measurement of infarct volume

Results—Significantly decreased CSF levels of sFas/APO-1 were observed during the entire observation period, with a maximal decrease on day 21 after the onset of stroke. The intrathecal levels of sFas/APO-1 were significantly negatively correlated with the volume of brain infarct and with the neurological deficit 3 weeks and 3 months after the onset of the stroke. In addition, the intrathecal levels of sFas/APO-1 were significantly correlated with the levels of IL-1ß, IL-6, IL-10, and GM-CSF 3 weeks after the onset of the disease. The intrathecal levels of sbcl-2 were significantly decreased during the first 3 days after stroke onset and at the same time were positively correlated with the levels of IL-6 and tumor necrosis factor-.

Conclusions—Our study demonstrates decreased intrathecal levels of proteins with antiapoptotic properties, suggesting that patients with acute stroke display a propensity toward apoptosis. Control of factors regulating apoptosis may lead to decreased delayed brain damage in stroke.

Key Words: apoptosis • brain • cerebrospinal fluid • cytokines • magnetic resonance imaging • proteins • stroke

This article has been cited by other articles:

				P. Delgado, E. Cuadrado, A. Rosell, J. Alvarez-Sabin, A. Ortega-Aznar, M. Hernandez-Guillamon, A. Penalba, C. A. Molina, and J. Montaner Fas System Activation in Perihematomal Areas After Spontaneous Intracerebral Hemorrhage Stroke, June 1, 2008; 39(6): 1730 - 1734. [Abstract] [Full Text] [PDF]

				N. Vila, J. Castillo, A. Davalos, A. Esteve, A. M. Planas, and A. Chamorro Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke Stroke, March 1, 2003; 34(3): 671 - 675. [Abstract] [Full Text] [PDF]

				W. Gartner, W. Lang, F. Leutmetzer, H. Domanovits, W. Waldhausl, and L. Wagner Cerebral Expression and Serum Detectability of Secretagogin, a Recently Cloned EF-hand Ca2+ -binding Protein Cereb Cortex, December 1, 2001; 11(12): 1161 - 1169. [Abstract] [Full Text] [PDF]

				U Felderhoff-Mueser, R Herold, F Hochhaus, P Koehne, E Ring-Mrozik, M Obladen, and C Bührer Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus Arch. Dis. Child., April 1, 2001; 84(4): 369 - 372. [Abstract] [Full Text]

				N. Vila, J. Castillo, A. Davalos, and A. Chamorro Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke Stroke, October 1, 2000; 31(10): 2325 - 2329. [Abstract] [Full Text] [PDF]